Medtronic plc (MDT)
NYSE: MDT · IEX Real-Time Price · USD
79.48
-1.73 (-2.13%)
At close: Jul 19, 2024, 4:00 PM
79.88
+0.40 (0.50%)
Pre-market: Jul 22, 2024, 7:34 AM EDT
Medtronic Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Medtronic stock have an average target of 90.82, with a low estimate of 76 and a high estimate of 105. The average target predicts an increase of 14.27% from the current stock price of 79.48.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medtronic stock from 12 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 5 | 5 | 5 | 2 | 2 | 2 |
Hold | 4 | 4 | 4 | 5 | 5 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 2 | 2 | 2 |
Total | 13 | 13 | 13 | 12 | 12 | 12 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Reiterates $92 | Hold | Reiterates | $92 | +15.75% | Jul 17, 2024 |
Truist Securities | Truist Securities | Hold Maintains $88 → $85 | Hold | Maintains | $88 → $85 | +6.95% | Jul 16, 2024 |
Citigroup | Citigroup | Hold Maintains $90 → $85 | Hold | Maintains | $90 → $85 | +6.95% | Jul 10, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $92 | Hold | Reiterates | $92 | +15.75% | Jun 5, 2024 |
Goldman Sachs | Goldman Sachs | Strong Sell Initiates $83 | Strong Sell | Initiates | $83 | +4.43% | May 30, 2024 |
Financial Forecast
Revenue This Year
33.74B
from 32.36B
Increased by 4.26%
Revenue Next Year
35.35B
from 33.74B
Increased by 4.76%
EPS This Year
5.49
from 2.76
Increased by 99.01%
EPS Next Year
5.88
from 5.49
Increased by 7.00%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 35.3B | 37.2B | 39.9B | 42.3B | 42.8B |
Avg | 33.7B | 35.3B | 37.1B | 39.3B | 41.0B |
Low | 32.6B | 33.7B | 34.9B | 37.8B | 39.6B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 9.0% | 10.1% | 13.0% | 14.1% | 8.8% |
Avg | 4.3% | 4.8% | 4.9% | 6.0% | 4.3% |
Low | 0.8% | -0.0% | -1.3% | 1.8% | 0.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.75 | 6.27 | 6.72 | 7.25 | 7.98 |
Avg | 5.49 | 5.88 | 6.29 | 6.83 | 7.46 |
Low | 5.30 | 5.51 | 5.75 | 6.37 | 7.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 108.5% | 14.1% | 14.3% | 15.2% | 16.8% |
Avg | 99.0% | 7.0% | 7.0% | 8.7% | 9.2% |
Low | 92.0% | 0.3% | -2.1% | 1.3% | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.